Sign In
Buy OPRX
$6.05
-0.220 (-3.51%)
At Close: Jul 31, 2026
OptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call Transcript
08:09pm, Tuesday, 09'th Nov 2021
OptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call Transcript
OPRX Stock: $102 Price Target From B. Riley
03:30pm, Tuesday, 19'th Oct 2021
The shares of OptimizeRx Corporation (NASDAQ: OPRX) have received a price target of $102 from B. Riley. These are the details.
Why Would Doctors Use OptimizeRx?
08:30am, Sunday, 03'rd Oct 2021
Here's how OptimizeRx gets in front of physicians.
This Healthcare Tech Stock Wants to Cut Out the Middleman
09:00am, Saturday, 02'nd Oct 2021
OptimizeRx connects pharmaceutical companies directly with physicians.
Doug Baker transitions to executive vice president of finance and accounting Doug Baker transitions to executive vice president of finance and accounting
OptimizeRx Survey Demonstrates Value of Digital Solutions in Addressing Unmet Patient and Provider Needs in Diabetes
08:00am, Wednesday, 29'th Sep 2021
Digital solutions provide new opportunities to support brand and HCP patient engagement challenges in survey of top U.S. endocrinologists Digital solutions provide new opportunities to support brand a
The Companies' combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction The Companies' combined point-of-care-engine creates an unmatched network of direct
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call Transcript
10:05pm, Wednesday, 04'th Aug 2021
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call Transcript
OptimizeRx: Q2 Earnings Insights
05:04pm, Wednesday, 04'th Aug 2021
Shares of OptimizeRx (NASDAQ:OPRX) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 400.00% year over year to $0.10, which beat t
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
08:00am, Tuesday, 27'th Jul 2021
ROCHESTER, Mich., July 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patie
2 Top Small-Cap Stocks to Buy in July
06:39am, Thursday, 08'th Jul 2021
OptimizeRx and Nano-X Imaging are two of my favorite small-caps right now. Here's why.
The 1 Stock I'd Buy Right Now
05:49am, Saturday, 03'rd Jul 2021
I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that.
OptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Here's Why
12:46pm, Thursday, 01'st Jul 2021
OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021
08:00am, Tuesday, 11'th May 2021
ROCHESTER, Mich., May 11, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patien
OptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2021 Results - Earnings Call Transcript
09:46am, Sunday, 09'th May 2021
OptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2021 Results - Earnings Call Transcript
